The Challenge
Physician investors can often lose money on medtech startups if they rely solely on personal relationships and limited deal flow instead of professional due diligence. With 30-60% of early-stage investments failing, most doctors are essentially gambling with their capital while missing the best opportunities that never reach traditional medical conferences or trade shows.